Cargando…
Hypothyroidism as an immune-related adverse event caused by atezolizumab in a patient with muscle spasms: a case report
A 60-year-old man with a history of 4 cycles of atezolizumab treatment for non-small cell lung cancer presented to our hospital with a chief complaint of proximal muscle-dominant spasms. Blood tests showed elevated creatine phosphokinase (CPK) of 8450 U/L and hypothyroidism. There was little improve...
Autores principales: | Kawataki, Masanori, Nakanishi, Yosuke, Yokoyama, Toshihide, Ishida, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792264/ https://www.ncbi.nlm.nih.gov/pubmed/35116222 http://dx.doi.org/10.1016/j.rmcr.2022.101585 |
Ejemplares similares
-
Air embolism after transbronchial lung cryobiopsy: A case report
por: Kawataki, Masanori, et al.
Publicado: (2022) -
Baseline risk factors associated with immune related adverse events and atezolizumab
por: Madjar, Katrin, et al.
Publicado: (2023) -
Atezolizumab induced immune-related adverse event mimicking conjunctival metastatic disease
por: Aschauer, Julia, et al.
Publicado: (2022) -
Pneumonia Due to Human Coronavirus OC43 in an Immunocompetent Adult Detected by Multiplex Polymerase Chain Reaction
por: Kawataki, Masanori, et al.
Publicado: (2021) -
Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab
por: Honma, Yuichi, et al.
Publicado: (2021)